Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 8 USDMF, 1 CEP/COS, 4 NDC API, 2 Listed Suppliers

9 API Suppliers
8 USDMF
1 CEP/COS
4 NDC API
2 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

9 FDF Dossiers, 8 FDA Orange Book, 1 Listed Dossiers

9 FDF Dossiers
8 FDA Orange Book
1 Listed Dossiers

DIGITAL CONTENT

9 NEWS #PharmaBuzz

media
9 NEWS #PharmaBuzz

MARKET PLACE

1 APIs

marketPlace
1 APIs

REF. STANDARDS & IMPURITIES

1 USP , 1 Others

otherSolutions
1 USP
1 Others

Axplora Triamcinolone Diacetate

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 67-78-7, Polcortolon, Aristocort forte, Tedarol, Triamcinolone 16,21-diacetate, Orion

Molecular Formula

C₂₅H₃₁FO₈

Molecular Weight

478.5 g/mol

InChI Key

XGMPVBXKDAHORN-RBWIMXSLSA-N

FDA UNII

A73MM2Q32P

1 2D Structure

Triamcinolone Diacetate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

[2-[(8S,9R,10S,11S,13S,14S,16R,17S)-16-acetyloxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate

2.1.2 InChI

InChI=1S/C25H31FO8/c1-13(27)33-12-20(31)25(32)21(34-14(2)28)10-18-17-6-5-15-9-16(29)7-8-22(15,3)24(17,26)19(30)11-23(18,25)4/h7-9,17-19,21,30,32H,5-6,10-12H2,1-4H3/t17-,18-,19-,21+,22-,23-,24-,25+/m0/s1

2.1.3 InChI Key

XGMPVBXKDAHORN-RBWIMXSLSA-N

2.1.4 Canonical SMILES

CC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)OC(=O)C)O

2.1.5 Isomeric SMILES

CC(=O)OCC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)OC(=O)C)O

2.2 Other Identifiers

2.2.1 UNII

A73MM2Q32P

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Polcartolone

2. Polcortolon

2.3.2 Depositor-Supplied Synonyms

1. 67-78-7

2. Polcortolon

3. Aristocort Forte

4. Tedarol

5. Triamcinolone 16,21-diacetate

6. Orion

7. Aristocort Diacetate

8. Kenacourt

9. Aristocort Syrup

10. Chebi:9669

11. Aristocort Parenterals

12. Kenacort Diacetate Syrup

13. A73mm2q32p

14. Aristocort Diacetate Forte

15. Aristocort Forte Parenteral

16. Nsc-757356

17. Ncgc00159320-03

18. Dsstox_cid_28639

19. Dsstox_rid_82909

20. Pregna-1,4-diene-3,20-dione,16,21-bis(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11b,16a)-

21. Dsstox_gsid_48713

22. Cas-67-78-7

23. [2-[(8s,9r,10s,11s,13s,14s,16r,17s)-16-acetyloxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Acetate

24. Triamcinolone Diacetate [jan]

25. 357rp

26. Einecs 200-669-0

27. Triamcinolone 16-alpha,21-di(acetate)

28. Unii-a73mm2q32p

29. Triamcinolone Diacetate [usp:jan]

30. 16alpha-hydroxy-9alpha-fluoroprednisolone Diacetate

31. 9-alpha-fluoro-16-alpha-hydroxyprednisolone Diacetate

32. Delta1,9alpha-fluoro-16alpha-hydroxyhydrocortisone Diacetate

33. Delta11,16alpha-hydroxy-9alpha-fluorohydrocortisone Diacetate

34. 16alpha,21-diacetoxy-9alpha-fluoro-11beta,17alpha-dihydroxy-1,4-pregnadiene-3,20-dione

35. 9-fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,21-diacetate

36. 9-fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,21-diacetate

37. Schembl12549

38. Pregna-1,4-diene-3,20-dione, 16,21-bis(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11beta,16alpha)-

39. Chembl1200449

40. Dtxsid0048713

41. Triamcinolone Diacetate (jan/usp)

42. Zinc3875441

43. Tox21_113119

44. Bdbm50247986

45. Akos025402044

46. Tox21_113119_1

47. Ac-3522

48. Nsc 757356

49. Triamcinolone Diacetate [mart.]

50. Triamcinolone Diacetate [vandf]

51. Triamcinolone Diacetate [usp-rs]

52. Triamcinolone Diacetate [who-dd]

53. Ncgc00159320-02

54. Ncgc00159320-04

55. Pregna-1,4-diene-2,20-dione, 9-fluoro-11-beta,16-alpha,17,21-tetrahydroxy-, 16,21-diacetate

56. T3676

57. Triamcinolone 16,21-diacetate [mi]

58. Triamcinolone Diacetate [orange Book]

59. Triamcinolone Impurity A [ep Impurity]

60. C08184

61. D00984

62. Triamcinolone Diacetate [usp Monograph]

63. 056t462

64. Q-201856

65. Q27108462

66. Triamcinolone Diacetate, United States Pharmacopeia (usp) Reference Standard

67. 9-fluoro-11b,16a,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,21-diacetate

68. 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,21-diacetate

2.4 Create Date

2005-06-24

3 Chemical and Physical Properties

Molecular Formula	C₂₅H₃₁FO₈
Molecular Weight	478.5 g/mol
XLogP3	1.9
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	6
Exact Mass	478.20029610 g/mol
Monoisotopic Mass	478.20029610 g/mol
Topological Polar Surface Area	127 Å²
Heavy Atom Count	34
Formal Charge	0
Complexity	1020
Isotope Atom Count	0
Defined Atom Stereocenter Count	8
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)

API SUPPLIERS